Diagnosis of breast cancer by tear proteomic pattern

Cancer Genomics and Proteomics

Volumn 6, Issue 3, 2009, Pages 177-182

  Lebrecht, Antje ^a   Boehm, Daniel ^a   Schmidt, Markus ^a   Koelbl, Heinz ^a   Schwirz, Raphaela L ^a   Grus, Franz H ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Biomarkers; Breast cancer; Proteomics; SELDI TOF MS; Tear fluid

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SCREENING; CATION EXCHANGE; CONTROLLED STUDY; FEMALE; HUMAN; LACRIMAL FLUID; MAJOR CLINICAL STUDY; MOLECULAR WEIGHT; PROTEIN DETERMINATION; PROTEOMICS; REVERSED PHASE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

EID: 67649506543     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics. CA Cancer. J Clin 55: 74-108, 2005. (Pubitemid 40372904)
2. Keemers-Gels ME, Groenendijk RP, van den Heuvel JH, Boetes C, Peer PG and Wobbes TH: Pain experienced by women attending breast cancer screening. Breast Cancer Res Treat 60: 235-240, 2000. (Pubitemid 30440539)
3. Antman K and Shea S: Screening mammography under age 50. JAMA 281: 1470-1472, 1999. (Pubitemid 29200919)
4. Jackson VP, Lex AM and Smith DJ: Patient discomfort during screen-film mammography. Radiology 168(2): 421-423, 1988. (Pubitemid 18184466)
5. Cockburn J, Cawson J, Hill D and De Luise T: An analysis of attenders at an Australian pilot breast cancer screening Programm. Australas Radiol 36: 115-119, 1992.
6. Aro AR, Absetz-Ylostalo P, Eerola T, Pamilo M and Lonnqvist J: Pain and discomfort during mammography. Eur J Cancer 32A(10): 1674-1679, 1996. (Pubitemid 26306876)
7. Cheung KL, Graves CR and Robertson JF: Tumour marker measurements in the diagnosis and monitoring of breast cancer. Cancer Treat Rev 26(2): 91-102, 2000 (Pubitemid 30182241)
8. Clarke CH, Buckley JA and Fung ET: SELDI-TOF-MS proteomics of breast cancer. Clin Chem Lab Med 43(12): 1314-1320, 2005.
9. Lebrecht A, Boehm D, Schmidt M, Koelbl H and Grus FH: Surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry to detect breast cancer markers in tears and serum. Cancer Genomics Proteomics 6: in press, 2009.
10. Grus FH, Joachim SC and Pfeiffer N: Analysis of complex autoantibody repertoires by surface-enhanced laser desorption/ionization-time of flight mass spectrometry. Proteomics 3: 957-961, 2003. (Pubitemid 36801683)
11. Petricoin EF 3rd, Ornstein DK, Paweletz CP, Ardekani A, Hackett PS, Hitt BA, Velassco A, Trucco C, Wiegand L, Wood K, Simone CB, Levine PJ, Linehan WM, Emmert-Buck MR, Steinberg SM, Kohn EC and Liotta LA: Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 94: 1576-1578, 2002.
12. Semmes OJ, Feng Z, Adam BL, Banez LL, Bigbee WL, Campos D, Cazares LH, Chan DW, Grizzle WE, Izbicka E, Kagan J, Malik G, McLerran D, Moul JW, Partin A, Prasanna P, Rosenzweig J, Sokoll LJ, Srivastava S, Srivastava S, Thompson I, Welsh MJ, White N, Winget M, Yasui Y, Zhang Z and Zhu L: Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. Clin Chem 51: 102-112, 2005.
13. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC and Liotta LA: Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359: 572-577, 2002. (Pubitemid 34178440)
14. Chen YD, Zheng S, Yu JK and Hu X: Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population. Clin Cancer Res 10: 8380-8385, 2004. (Pubitemid 40053400)
15. Yu JK, Cheng YD and Zheng S: An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics. World J Gastroenterol 10: 3127-3131, 2004. (Pubitemid 39419872)
16. Herber S, Grus FH, Sabuncuo P and Augustin AJ: Changes in the tear protein patterns of diabetic patients using two-dimensional elecrophoresis. Adv Exp Med Biol 506: 623-626, 2002. (Pubitemid 36312998)
17. Stolwijk TR, Kuizenga A van Haeringen NJ, Kijlstra A, Oosterhuis JA and van Best JA: Analysis of tear fluid proteins in insulin-dependent diabetes mellitus. Acta Ophthalmol 72: 357-362, 1994. (Pubitemid 24222017)
18. Tomosugi N, Kitagawa K, Takahashi N, Sugai S and Ishkawa I: Diagnostic potential of tear proteomic patterns in Sjogren's syndrome. J Proteome Res 4: 820-825, 2005. (Pubitemid 40863270)
19. An HJ, Ninonuevo M, Agulan J, Liu H, Lebrilla CB, Alvarenga LS and Mannis MJ: Glycomics analyses of tear fluid for the diagnostic detection of ocular rosacea. J Proteome Res 4: 1981-1987, 2005.
20. Janssen PT and van Bijsterveld OP: Origin and biosynthesis of human tear fluid proteins. Invest Ophthalmol Vis SCI 24: 623-630, 1983.
21. Sariri R and Ghafoori H: Tear proteins in health, disease, and contact lens wear. Biochemistry 73: 381-392, 2008. (Pubitemid 351653595)
22. Van Haeringen NJ: Clinical biochemistry of tears. Surv Ophthalmol 26: 84-96, 1981. (Pubitemid 11022563)
23. Tiffany JM: The normal tear film. Dev Ophthalmol 41: 1-20, 2008.
24. Rumelhart D, Hinton G and Williams J: Learning representations by back-propagating procedures. Nature 323: 533-536, 1986.
25. Francisci S, Capocaccia R, Grande E, Santaquilani M, Simonetti A, Allemani C, Gatta G, Sant M, Zigon G, Bray F and Janssen-Heijnen M; EUROCARE Working Group: The cure of cancer: a European perspective. Eur J Cancer 45(6): 1067-1079, Epub 2009.
26. Smith RA, Cokkinides V and Eyre HJ: American Cancer Society. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 54: 41-52, 2004. (Pubitemid 38443419)
27. Davis MA and Hanash S: High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy. Breast Cancer Res 8: 217, 2006.
28. Pawlik TM, Fritsche H, Coombes KR, Xiao L, Krishnamurthy S, Hunt KK, Pusztai L, Cheng J, Clarke CH, Arun B, Hung M and Kuerer HM: Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry. Breast Cancer Res Treat 89(2): 149-157, 2005. (Pubitemid 40253557)
29. Kuerer HM, Goldknopf IL, Fritsche H, Krishnamurthy S, Sheta EA and Hunt KK: Identification of distinct protein expression patterns in bilateral matched pair breast ductal fluid specimens from women with unilateral invasive breast carcinoma. Cancer 95: 2276-2282, 2002. (Pubitemid 35351132)
30. Wulfkuhle JD, Paweletz CP, Steeg PS, Petricoin EF and Liotta L: Proteomic approaches to the diagnosis, treatment, and monitoring of cancer. Adv Exp Med Biol 532: 59-68, 2003. (Pubitemid 37176780)
31. Li J, Zhang Z, Rosenzweig J, Wang YY and Chan DW: Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 48: 1296-1304, 2002. (Pubitemid 34809839)
32. Streckfus CF, Bigler LR and Zwick M: The use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: a feasibility study. J Oral Oathol Med 35: 292-300, 2006.
33. Streckfus CF and Bigler LR: Saliva as a diagnostic fluid. Oral Disease 8: 69-76, 2002. (Pubitemid 34298345)